Q2 2026 Holdings
Filed 2026-08-05 | 2 holdings | $229.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc.(MLYS) | COM | 603170101 | $213.2M | 7,903,838 | 92.9% |
| Phathom Pharmaceuticals, Inc.(PHAT) | COM | 71722W107 | $16.2M | 1,493,854 | 7.1% |